The Ryan White CARE Act is a federal program that provides medical care, medications, and support services to low-income Americans living with HIV who have limited or no health insurance. Congress passed it in 1990 as Public Law 101-381, and it remains the largest federally funded program specifically for people with HIV, with roughly $2.57 billion allocated in fiscal year 2025.
Who Was Ryan White
Ryan White was an Indiana teenager who contracted HIV through a blood transfusion used to treat his hemophilia. After his diagnosis, he was barred from attending school and faced intense discrimination from his community. His public fight against that stigma made him one of the most visible AIDS advocates in the country during the late 1980s, helping shift public understanding of HIV at a time when fear and misinformation were widespread.
White died on April 8, 1990, at age 19. Just a few months later, Congress passed the act bearing his name by wide, bipartisan margins in both houses. The legislation was designed to help states, communities, and families cope with the growing AIDS epidemic by building a safety net of care for people who had nowhere else to turn.
How the Program Works
The Ryan White HIV/AIDS Program functions as a “payer of last resort.” That means it only covers services that no other insurance, public program, or funding source will pay for. If you have Medicaid, Medicare, or private insurance, those must be billed first. Ryan White funds fill the gaps, covering what’s left over or providing care when no other coverage exists at all.
The program is organized into several parts, each targeting a different piece of the HIV care system:
- Part A sends formula grants to metropolitan areas hardest hit by HIV, funding core medical services and support in those communities.
- Part B provides grants to every state and territory. Its most well-known component is the AIDS Drug Assistance Program, or ADAP, which covers the cost of HIV medications for people who can’t afford them.
- Part C funds community-based clinics and health centers that deliver outpatient HIV care directly to patients.
- Part D focuses on women, infants, children, and youth living with HIV, funding family-centered care.
- Part F supports provider training, dental programs, and initiatives that address racial and ethnic disparities in HIV care.
Who Qualifies
To receive services through the program, you need to meet three basic requirements: a documented HIV diagnosis, low income, and residency within the service area of a local program. There is no single national income cutoff. Each local program defines “low income” based on a percentage of the federal poverty level, and those thresholds vary by location. In practice, the program primarily serves people who are uninsured, underinsured, or enrolled in Medicaid but still have gaps in their coverage.
You don’t need to be a U.S. citizen to qualify. Immigration status is not a federal eligibility requirement, though individual programs may have their own residency definitions.
Medications Through ADAP
For many people, the most critical benefit is access to HIV medications. The AIDS Drug Assistance Program, funded under Part B, pays for FDA-approved antiretroviral drugs for people who otherwise couldn’t afford them. Each state runs its own ADAP and decides which specific medications to cover, but every state program must include at least one drug from each class of HIV antiretrovirals on its list.
ADAP funds can also be used to purchase health insurance for eligible clients, which often stretches the program’s reach further. Some states use ADAP dollars to pay insurance premiums or copays, keeping people enrolled in coverage that handles most of their medical needs while ADAP covers the HIV-specific costs that remain.
Support Services Beyond Medication
HIV treatment works best when people can actually get to appointments, stay housed, and manage the logistics of daily life. The program funds a range of non-medical support services designed to keep people in care. These can include transportation to clinic visits, case management, housing assistance, mental health services, substance use treatment, and help with food and nutrition. The exact mix of support services varies by location and depends on what each community identifies as its greatest barriers to care.
Addressing Racial and Ethnic Disparities
HIV disproportionately affects Black, Latino, and other minority communities in the United States. The Minority AIDS Initiative, codified in 2006, provides additional funding across all parts of the Ryan White program to close those gaps. Under Part A, those funds go toward core medical services in hard-hit metro areas. Under Part B, they support outreach and education to increase access to medications. Parts C and D direct money toward culturally and linguistically appropriate care for minority adults, women, children, and youth. Part F funds training so that more healthcare providers develop expertise in treating minority patients with HIV.
Training the HIV Workforce
Part F also funds the AIDS Education and Training Center Program, a national network of HIV experts who train healthcare providers. The program targets physicians, nurses, advanced practice nurses, physician associates, pharmacists, and oral health professionals. Training covers everything from the basics of HIV testing and prevention to complex patient management. The network also runs the National HIV Curriculum, a free online resource that offers continuing education credits for health professionals. The goal is straightforward: make sure there are enough providers across the country who know how to diagnose, treat, and counsel people living with HIV.
How Effective the Program Has Been
The clearest measure of success in HIV treatment is viral suppression, the point at which medication reduces the virus in someone’s blood to undetectable levels. A person who is virally suppressed stays healthier and cannot transmit HIV sexually. In 2024, 91.4% of Ryan White patients receiving HIV medical care were virally suppressed, a record high that significantly exceeds the national average. That number reflects what the program is designed to do: connect people to care, keep them in care, and make sure they can access the medications that control the virus.
The program now serves hundreds of thousands of people annually across all 50 states and U.S. territories. For many of them, it is the difference between consistent, life-sustaining treatment and going without.